The Native Antigen Company is an expert in the production of bacterial and viral antigens, specialising in the development and manufacture of native and recombinant viral and bacterial antigens.
Bio-Rad Laboratories has launched a range of anti-idiotypic antibodies targeting the immune checkpoint inhibitor drugs pembrolizumab (Keytruda) and nivolumab (Opdivo). Anti-pembrolizumab and anti-nivolumab antibodies are designed for use in bioanalytical assays to monitor the drug levels in cancer patients.
Bio-Rad's anti-vedolizumab antibodies include four recombinant monoclonal anti-idiotypic antibodies that are highly specific for the humanised IgG1 kappa antibody drug vedolizumab, and are suitable for development of bioanalytical and patient monitoring assays.
Bio-Rad Laboratories has announced the StarBright Blue 520 Fluorescent Secondary Antibodies — fluorescent dye-labelled secondary antibodies for use in multiplex western blotting.
AdipoGen Life Sciences' anti-α-Tubulin monoclonal antibodies (recombinant) are composed of human variable regions (VH and VL) (λ-chain) of immunoglobulin fused to the human lgG2 Fc domain.
EpiGentek has released a monoclonal antibody that is specific to Staphylococcus aureus Cas9 (SaCas9) and enables easy and specific monitoring of gene editing processes.
Abcam has combined the advantages of its RabMAb rabbit monoclonals with recombinant technology to deliver high-performance antibodies.
ProSci's Risk-Free Antibody Sets consist of several monoclonal antibodies (20 µg each) against a single target, allowing selection of the best clone for specific applications. Antibodies were developed using recombinant proteins expressed in mammalian cells to best recognise the native proteins.
Antibodies displaying an agonist or antagonist activity (functional grade antibodies) are powerful tools for mimicking or blocking physiological functions in vitro and in vivo. AdipoGen Life Sciences offers an extensive range of functional antibodies (FuncAbs).
Vector Laboratories introduces the VectaFluor Duet kit, offering convenient, ready-to-use immunofluorescence double labelling. The kit is suitable for use with a wide range of frozen and FFPE tissue samples, combining primary and secondary antibodies to streamline workflow.
Agrisera offers a large collection of validated antibodies. The company has antibodies for a range of important targets in the thylakoid membrane and beyond, including the Rubisco antibody.
GeneTex is conducting knockdown-based validation as a fundamental component of its antibody quality assurance process. To date, the compnany has evaluated over 500 products covering research topics such as apoptosis, metabolism, epithelial–mesenchymal transition and neurodegenerative diseases.
GeneTex has over 60 Cancer Immune Checkpoint Antibodies to choose from, including key targets such as CTLA4, FOXP3, LAG3, OX40L and PD-L1, with validations across various applications.
Japanese researchers have reported the effect of a particular type of monoclonal antibody on epilepsy in mice, with promising results.
GeneTex offers a comprehensive catalogue of antibodies to dengue virus (DENV) structural and non-structural viral proteins.